Lung Cancer Diagnosis and TreatmentRadiomics and Machine Learning in Medical ImagingLung Cancer Treatments and MutationsAsthma and respiratory diseasesCancer Immunotherapy and Biomarkers
Publications
213
Citations
3,266
Est. group size
—
Recurring co-author estimate
Active years
29
Publishing since 1997
Publication cadence
Publications per year over the last 10 years — averaging 16.6/year recently
Recent publications
- Clinicopathological characteristics, genetic aberrations, and optimized treatment strategies in double-hit and triple-hit lymphoma: a multi-center cohort study
Molecular Biomedicine · 2025
- Clinical outcomes and safety of tislelizumab maintenance therapy following autologous stem cell transplantation in patients with relapsed or refractory diffuse large b-cell lymphoma
Blood · 2025
- Cross-species standardised cortico-subcortical tractography
eLife · 2025
- Author response: Cross-species standardised cortico-subcortical tractography
2025
- 741P Chemoradiotherapy (CRT) followed by sequential tislelizumab (TIS) + CAPOX and TIS for organ preservation in low rectal cancer (RELIEVE-01): Primary results
Annals of Oncology · 2025
- Clinical characteristics and molecular heterogeneity in Follicular lymphoma with extranodal involvement
Genome Medicine · 2025
- Identification of C4BPA as a genetically informed drug target in NSCLC: an integrative single-cell and multi-omics study based on the druggable genes
Human Genomics · 2025
- The primate brain connectivity bauplan and human-specific variations
Evolution of Nervous Systems · 2025
- Author response: Cross-species Standardised Cortico-Subcortical Tractography
2025
- Cross-species Standardised Cortico-Subcortical Tractography
eLife · 2025
- What needs to be standardized for reliable, reproducible, and robust tractography?
2025
- Cross-species Standardised Cortico-Subcortical Tractography
eLife · 2025
- 178 | CLINICAL CHARACTERISTICS AND MOLECULAR HETEROGENEITY IN FOLLICULAR LYMPHOMA WITH EXTRANODAL INVOLVEMENT
Hematological Oncology · 2025
- Identification of C4BPA as a genetically informed drug target in NSCLC: An integrative single-cell and multi-omics study based on the druggable genes
Research Square · 2025
- Prognostic Value of 18F-FDG PET/CT in Neoadjuvant PD-1 Inhibitor-treated NSCLC
Clinical Nuclear Medicine · 2025
Publishes in
- PubMed×8
- Research Square×6
- Frontiers in Oncology×5
- Blood×5
- eLife×4
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 9, 2026.
Claim or correct this profile